Cellectar Biosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLRB and other ETFs, options, and stocks.About CLRB
Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124, which could detect tumors and metastases in a broad range of cancers, and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination.
CLRB Key Statistics
Stock Snapshot
Cellectar Biosciences(CLRB) stock is priced at $2.74, giving the company a market capitalization of 11.79M. It carries a P/E multiple of -0.26.
On 2025-12-18, Cellectar Biosciences(CLRB) stock traded between a low of $2.74 and a high of $2.74. Shares are currently priced at $2.74, which is 0.0% above the low and 0.0% below the high.
The Cellectar Biosciences(CLRB)'s current trading volume is 413, compared to an average daily volume of 71.55K.
During the past year, Cellectar Biosciences(CLRB) stock moved between $2.45 at its lowest and $20.59 at its peak.
During the past year, Cellectar Biosciences(CLRB) stock moved between $2.45 at its lowest and $20.59 at its peak.
CLRB News
Cellectar Biosciences (CLRB) announced a multi-year supply agreement with Ionetix Corporation, a leading cyclotron technology innovator and full-service radiois...